Copper chelation therapy inhibits renal fibrosis by modulating copper transport proteins
- 24 March 2022
- journal article
- research article
- Published by Wiley in BioFactors
- Vol. 48 (4) , 934-945
Abstract
The copper (Cu) transporter proteins play an important role in the maintenance of the Cu homeostasis in the body. Lysyl oxidase (LOX) proteins are involved in crosslinking of collagens and elastin molecules resulting in the establishment of extracellular matrix (ECM) and require Cu for their functional activity. Although there are few reports showing the protective effects of Cu chelators, the mechanism behind protection remains unknown. The present study investigated the role of Cu transporter proteins in renal fibrosis. We used tubular epithelial cells and three different animal models of renal injury to investigate the induction of Cu transporter proteins in renal injury with different etiology. We used disulfiram, clioquinol as two Cu chelators and ammonium tetrathiomolybdate as a standard Cu chelator. In addition, β‐aminopropionitrile (BAPN) was used as a standard LOX inhibitor. We demonstrated that renal fibrosis is associated with the induction of Cu transporter proteins such as ATP7A and Copper Transporter 1 (CTR1) but the Cu overload did not induce renal fibrosis. In addition, the Cu chelators inhibited renal fibrosis by inhibiting the Cu transporter proteins.Keywords
This publication has 32 references indexed in Scilit:
- Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancerInvestigational New Drugs, 2012
- Advances in the Understanding of Mammalian Copper TransportersAdvances in Nutrition, 2011
- Copper Transport Activity of Yeast Ctr1 Is Down-regulated via Its C Terminus in Response to Excess CopperJournal of Biological Chemistry, 2009
- Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cellsFree Radical Biology and Medicine, 2007
- Function and Regulation of Human Copper-Transporting ATPasesPhysiological Reviews, 2007
- Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome ActivityCancer Research, 2006
- Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2Journal of Hepatology, 2005
- Clioquinol Mediates Copper Uptake and Counteracts Copper Efflux Activities of the Amyloid Precursor Protein of Alzheimer's DiseaseJournal of Biological Chemistry, 2004
- Clioquinol, a Drug for Alzheimer's Disease Specifically Interfering with Brain Metal Metabolism: Structural Characterization of Its Zinc(II) and Copper(II) ComplexesInorganic Chemistry, 2004
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MiceNeuron, 2001